Acutaas Chemicals Q2FY26 Net Profit Soars 91% YoY to ₹71.85 Crore; Shares Hit ₹1,652.30 Mark, Up 6.37%

Mumbai, 17 October 2025: Acutaas Chemicals Limited (NSE: ACUTAAS) reported a strong set of quarterly earnings for the period ended 30 September 2025, with consolidated net profit surging 91.3% year-on-year to ₹71.85 crore, compared to ₹37.56 crore in Q2FY25. The stellar performance was driven by robust revenue growth, higher realisations, and improved operational efficiency.

Stock Snapshot

At 2:21 p.m. IST, Acutaas Chemicals Limited’s share price was trading 6.37% higher at ₹1,652.30, marking a gain of ₹98.90 from the previous close of ₹1,553.40. The stock hit an intra-day high of ₹1,652.50 and a low of ₹1,551.00, with a market capitalisation of ₹13,530 crore and a P/E ratio of 71.12. The rally aligns with the company’s improved profitability, which demonstrates resilience amid evolving sectoral dynamics within the speciality chemicals and pharmaceutical segments.

Revenue from Operations Rises 24.1% YoY and 47.8% QoQ, Reflecting Strong Demand Momentum

During Q2FY26, revenue from operations stood at ₹30,619.58 lakh, up 24.1% year-on-year from ₹24,673.36 lakh in Q2FY25, and 47.8% sequentially from ₹20,723.72 lakh in Q1FY26. The company benefited from sustained growth in its pharmaceutical and speciality chemicals division, supported by steady order inflows and improved pricing across key product categories.

The total income rose 23.9% YoY to ₹31,603.21 lakh, while profit before tax climbed 92.2% YoY to ₹9,617.98 lakh, aided by disciplined cost management and operational efficiencies.

Profit for the Quarter Jumps 91.3% YoY to ₹7,185.59 Lakh as Cost Controls Boost Margins

Acutaas Chemicals recorded a profit for the period at ₹7,185.59 lakh, a 91.3% increase YoY from ₹3,756.67 lakh and 63.3% QoQ from ₹4,401.05 lakh. This was primarily attributed to enhanced process efficiency and lower finance costs, which helped offset moderate raw material price hikes.

The earnings per share (EPS) for the quarter stood at ₹8.82, up 88.1% YoY and 63% sequentially, reflecting consistent earnings growth backed by stronger topline performance.

For the half-year ended FY26, total income reached ₹53,920.80 lakh, marking a 24.4% YoY increase, while net profit doubled to ₹11,586.64 lakh, compared to ₹5,225.64 lakh a year earlier—signalling a steady operational recovery.

Operational Efficiency and Segmental Growth Drive Overall Performance in Q2FY26

The company’s performance in Q2FY26 was underpinned by efficient capacity utilisation and improved cost rationalisation. Acutaas Chemicals reported better realisations in product sales, coupled with effective control over finance costs. Despite a marginal rise in raw material expenses, the company maintained healthy margins through optimised production planning.

Such strategic operational execution has helped the firm sustain double-digit growth both year-on-year and sequentially, underscoring its adaptability and sectoral strength.

Acutaas Chemicals’ sharp 91% YoY growth in profit and consistent expansion across both revenue and income metrics underline its operational strength and efficiency-driven approach. The company’s ability to manage costs while maintaining profitability positions it well within India’s expanding speciality chemicals and pharmaceutical ecosystem.

REF: https://nsearchives.nseindia.com/corporate/AMIORG_17102025120115_FRSWsigned.pdf

Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations